BOLERO-1 reports HER2-positive breast cancer latest PFS data

Comment: Tamoxifen lowered breast cancer rates among high-risk women

Impact of adding bevacizumab to presurgery chemo for triple-negative breast cancer varies with subtype

Fulvestrant improves survival over anastrozole for patients with advanced breast cancer

Progression-free survival results from BOLERO-1 trial

Lowering dietary fat intake reduces death rates in some women with breast cancer

Multigene test can predict risk of disease recurrence for women with ductal carcinoma in situ

Examining cell-free DNA provides non-invasive detection of malignancies in Hodgkin lymphoma

Ovarian suppression with tamoxifen reduced recurrence in some premenopausal breast cancer cases

Comment: Capecitabine for elderly early-stage breast cancer

Capecitabine monotherapy does not improve survival in elderly patients with early-stage breast cancer

Impact of adding bevacizumab to presurgery chemo for triple-negative breast cancer varies with subtype